EUVIMEDEUVIMED entdecken
Open Access

Methylation markers for anal cancer screening: A repeated cross‐sectional analysis of people living with HIV , 2015–2016

Anjali Vasavada, Helen C Stankiewicz Karita, John Lin, Jeffrey Schouten, Stephen E Hawes, Ruanne V Barnabas, Judith Wasserheit, Qinghua Feng, Rachel L Winer iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Anjali Vasavada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. Hauptthemen laut MEDLINE: DNA Methylation, Anus Neoplasms, HIV Infections, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with HIV (PLWH) are at highest risk of anal cancer and will benefit from optimized screening for early disease detection. We compared host DNA methylation markers in high‐grade squamous intraepithelial lesions (HSIL) versus samples negative for intraepithelial lesions (NILM) or low‐grade intraepithelial lesions (LSIL) in PLWH. We recruited PLWH identifying as male aged ≥18 years undergoing high‐resolution anoscopy (HRA) in Seattle, Washington, 2015–2016. Anal brush samples were collected for HPV detection, genotyping, and pyrosequencing methylation (host genes ASCL1, PAX1, FMN2, and ATP10A); clinical data were abstracted from medical records. We assessed associations between methylation and presence and extent of HSIL using generalized estimating equation logistic regression, adjusting for age, CD4 count and HIV viral load. Marker panels using HPV DNA and methylation were also evaluated to predict prevalent HSIL. We analyzed 125 samples from 85 participants (mean age 50.1; standard deviation 11.0 years). ASCL1 (adjusted odds ratio [aOR] per 1 unit increase mean percent methylation: 1.07, 95% CI: 1.01–1.13) and FMN2 (aOR per 1 unit increase mean percent methylation: 1.14, 95% CI: 1.08–1.20) methylation were significantly associated with HSIL versus NILM/LSIL. ASCL1 (aOR: 1.06, 95% CI: 1.01–1.11) and FMN2 (aOR: 1.13, 95% CI: 1.08–1.17) methylation were positively associated with increasing HSIL extent. A panel combining methylation (ASCL1 and FMN2) and HPV DNA (HPV16, HPV18, and HPV31) demonstrated best balance of sensitivity (78.2%) and specificity (73.9%) for HSIL detection compared with methylation or HPV alone. Increasing levels of DNA methylation of ASCL1 and FMN2 were positively associated with HSIL detection in PLWH. Host gene methylation testing shows promise for HSIL screening and triage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationAnus NeoplasmsHIV InfectionsEarly Detection of CancerPapillomavirus InfectionsHumansMaleMiddle AgedCross-Sectional StudiesAdultBasic Helix-Loop-Helix ProteinsBiomarkers, TumorSquamous Intraepithelial LesionsDNA, ViralAgedPaired Box Transcription Factors

Stichwörter der Autor:innen

HIVanal canceranal high‐grade squamous intraepithelial lesionhost cell DNA methylationhuman papillomavirus

Substanzen

Basic Helix-Loop-Helix ProteinsBiomarkers, TumorDNA, ViralPaired Box Transcription FactorsASCL1 protein, humanPAX1 transcription factor

Autor:innen und Institutionen

  • Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
  • Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Division of General Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Global Health, University of Washington School of Public Health, Seattle, Washington, USA.

ORCID-Profile: Rachel L Winer

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Vasavada, A., Stankiewicz Karita, H. C., Lin, J., Schouten, J., Hawes, S. E., Barnabas, R. V., Wasserheit, J., Feng, Q., & Winer, R. L. (2024). Methylation markers for anal cancer screening: A repeated cross‐sectional analysis of people living with HIV , 2015–2016. International Journal of Cancer. https://doi.org/10.1002/ijc.34977

Vancouver

Vasavada A, Stankiewicz Karita HC, Lin J, Schouten J, Hawes SE, Barnabas RV, et al. Methylation markers for anal cancer screening: A repeated cross‐sectional analysis of people living with HIV , 2015–2016. International Journal of Cancer. 2024. doi:10.1002/ijc.34977

BibTeX
@article{Vasavada2024,
  author = {Vasavada, Anjali and Stankiewicz Karita, Helen C and Lin, John and Schouten, Jeffrey and Hawes, Stephen E and Barnabas, Ruanne V and Wasserheit, Judith and Feng, Qinghua and Winer, Rachel L},
  title = {Methylation markers for anal cancer screening: A repeated cross‐sectional analysis of people living with HIV , 2015–2016},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34977}
}
Kostenlos starten →